Godbersen, C., Coupet, T. A., Huehls, A. M., Zhang, T., Battles, M. B., Fisher, J. L., . . . Sentman, C. L. (2017). NKG2D ligand targeted Bispecific T Cell Engagers lead to robust antitumor activity against diverse human tumors. Mol Cancer Ther.

Godbersen, Claire, Tiffany A. Coupet, Amelia M. Huehls, Tong Zhang, Michael B. Battles, Jan L. Fisher, Marc S. Ernstoff, und Charles L. Sentman. "NKG2D Ligand Targeted Bispecific T Cell Engagers Lead to Robust Antitumor Activity against Diverse Human Tumors." Mol Cancer Ther 2017.

Godbersen, Claire, et al. "NKG2D Ligand Targeted Bispecific T Cell Engagers Lead to Robust Antitumor Activity against Diverse Human Tumors." Mol Cancer Ther 2017.